Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Erdafitinib: one more tool for bladder cancer

Arlene Siefker-Radtke, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses how erdafitinib improves clinical outcomes in patients suffering from FGFR3-altered urothelial cancer. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.